Pioneer of Exposure Therapy for PTSD Dies, Highlighting Ongoing Gaps in Trauma Care
Edna Foa, the clinical psychologist whose relentless advocacy for confronting feared memories reshaped the treatment of post‑traumatic stress disorder, passed away at the age of 88, an event that, while marking the loss of a seminal figure, also casts a stark light on the enduring disparity between therapeutic innovation and its equitable delivery within contemporary mental‑health systems.
Born in the late 1930s and embarking on a career that would span more than half a century, Foa distinguished herself early on by challenging the prevailing therapeutic orthodoxy that favored avoidance of trauma‑related cues, instead proposing that systematic, controlled exposure to such cues could facilitate extinction of the anxiety response and foster recovery, a premise that gradually migrated from experimental clinics to the mainstream of evidence‑based practice through a combination of rigorous randomized trials, methodological refinements, and persistent lobbying of professional societies.
Over the ensuing decades, Foa’s exposure‑based protocols—initially developed for combat veterans and survivors of sexual assault—were iteratively adapted to address a spectrum of trauma‑related conditions, culminating in the establishment of the prolonged exposure model, which today enjoys endorsement from major health authorities and is incorporated into countless treatment manuals, training curricula, and insurance reimbursement structures, thereby cementing her legacy as a transformative architect of modern PTSD therapy.
Yet, despite the undeniable scientific validation and widespread institutional acceptance of the exposure approach, the very system that celebrates her contributions continues to grapple with structural shortcomings, most notably the chronic shortage of clinicians sufficiently trained to deliver the method with fidelity, the persistent stigma that deters many potential patients from seeking interventions predicated on confronting distressing memories, and the uneven allocation of resources that leaves large swaths of the population—particularly those in economically disadvantaged or rural settings—without reasonable access to the evidence‑based care for which Foa’s work has become synonymous.
In the months preceding her death, professional societies and academic institutions commemorated Foa’s contributions through a series of symposia, awards, and retrospectives that, while sincere in their intent, inadvertently underscored a paradox: the celebration of a therapeutic breakthrough that, fifty years after its inception, still fails to reach a majority of those who stand to benefit the most, a reality that invites contemplation of the systemic inertia that routinely translates scientific breakthroughs into policy and practice at a glacial pace.
Foa’s own writings repeatedly emphasized the ethical imperative for clinicians to not only master the technical aspects of exposure but also to cultivate a therapeutic alliance capable of navigating the inevitable discomfort that exposure engenders, a nuance that, in practice, is often eclipsed by administrative pressures, productivity metrics, and reimbursement models that prioritize brief, superficial encounters over the sustained, intensive engagement required for genuine trauma processing.
The timing of her passing, occurring amid a broader societal reckoning with the mental‑health fallout of recent global crises, accentuates the irony of a field that, while possessing a robust, empirically supported toolkit for addressing trauma, continues to wrestle with bureaucratic and cultural barriers that impede the translation of those tools into widespread, timely relief for the afflicted.
Moreover, the institutional reverence for Foa’s legacy has, in some quarters, fostered a complacency that assumes the mere existence of an evidence‑based protocol suffices to resolve PTSD at a population level, thereby obscuring the necessity for sustained investment in clinician training, public education, and the dismantling of systemic inequities that disproportionately deny marginalized communities the benefits of exposure‑based interventions.
As the mental‑health profession mourns the loss of a figure whose intellectual rigor and clinical compassion redefined the therapeutic landscape for trauma survivors, it is perhaps incumbent upon policymakers, educators, and practitioners to confront the disquieting reality that the life‑saving potential of exposure therapy remains underutilized, a circumstance that both honors and contradicts the very principles that guided Foa’s pioneering work: confronting discomfort directly, rather than allowing it to persist unnoticed beneath layers of institutional inertia.
In sum, the death of Edna Foa at 88 serves not merely as a moment of individual remembrance but as a poignant reminder that the maturation of a therapeutic paradigm does not, by default, guarantee its equitable implementation, and that the enduring challenge for the field lies in bridging the chasm between scientific advancement and the pragmatic, often politically fraught, realities of delivering comprehensive trauma care to all who need it.
Published: April 19, 2026